NewsRoom Articles - NetworkNewsWire

FridayMay 23, 2025 12:00 pm

Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Featured in Noble Research Report, Earns ‘Outperform’ Rating and C$0.70 and US$0.50 Price Target

Noble Capital Markets Research released a comprehensive analysis of Nicola Mining. Nicola distinguishes itself among junior mining companies by combining exploration potential with operational cash flow, report states. Noble report also noted the company’s “superb corporate governance,” led by CEO Peter Espig, former 20-year Goldman Sachs banker. Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF), a junior mining company based in British Columbia, has recently been the focus of a comprehensive analysis by Noble Capital Markets Research (https://nnw.fm/m8eHs). The report gave the company an "Outperform" rating and a 12-month price target of C$0.70 and US$0.50 per share while highlighting Nicola Mining's diversified asset…

FridayMay 23, 2025 11:15 am

Soligenix Inc. (NASDAQ: SNGX) Innovative Treatment to Combat Bacterial Infection Fills Urgent Need for Alternatives to Antibiotics

The overuse and misuse of antibiotics have led to the emergence of antibiotic-resistant bacteria, posing a significant threat to public health. Soligenix’s SGX943 is a novel broad-spectrum therapy designed to treat bacterial infections without relying on conventional antibiotics. Preclinical studies have demonstrated the efficacy of SGX943 in various models of bacterial infection. In the face of escalating antibiotic resistance, the medical community is urgently seeking alternative treatments for bacterial infections. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is at the forefront of this effort with its development of SGX943 (dusquetide), a novel broad-spectrum therapy designed to combat bacterial infections without relying…

FridayMay 23, 2025 10:30 am

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition

Kadima Neuropsychiatry Institute is expected to become the clinical model for HOPE Therapeutics’ nationwide network of psychiatric clinics. The acquisition brings profitability and is expected to be accretive to both revenue and EBITDA. Kadima’s founder and medical director, Dr. David Feifel, a leader in interventional psychiatry, will join HOPE as Chief Medical Innovation Officer. NRx’s pipeline includes investigational drugs for suicidal bipolar depression and chronic pain. HOPE is targeting 30 clinic acquisitions by the end of 2025, projecting $100M in annual revenue. NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly owned subsidiary HOPE Therapeutics, Inc., a medical…

FridayMay 23, 2025 9:45 am

FAVO Capital Inc. (FAVO): Positioned to Capitalize on Small Business Lending Revival

FAVO Capital has filed to uplist to Nasdaq, aiming to scale its private credit model U.S. small business lending is drawing renewed policy attention amid fintech innovation FAVO strengthening strategic partnership with Stewards Investment Capital Limited through Series A equity Investment Recently announced the voluntary conversion of all outstanding Super Voting Series C Preferred Shares into common stock As traditional banks retreat from Main Street, alternative lenders are stepping up to fill the gap, reshaping the $1.7 trillion small business lending market in the process. With policymakers calling for renewed focus on small business financing and digital platforms redefining borrower…

FridayMay 23, 2025 9:00 am

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows

Intelligent Bio Solutions remains on track for a 2025 U.S. launch of its non-invasive Intelligent Fingerprinting Drug Screening System. The company’s FDA 510(k) submission included validation studies showing 94.1% accuracy in detecting opiates through fingerprint sweat. INBS is already active in 24 countries, with over 450 commercial accounts globally, and adoption growing across diverse industries, including logistics, mining, retail, and marine operations. The firm is expanding its distributor network to support localized growth ahead of its U.S. market entry. Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing solutions, is preparing for its expected U.S.…

ThursdayMay 22, 2025 11:45 am

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Highlights Strength of Resource Opportunity at Metals Investor Forum

Recent interviews with ESGold Corp. officers highlight the company’s strategy to build revenue through clean technology mine tailings reclamation that will build into an exploration project at a legacy site in Quebec Officers for the Canada-based gold and silver development company have presented investor updates on ESGold’s timeline for production in a variety of forums and interviews, most recently at Canada’s Metals Investor Forum ESGold’s Montauban Gold-Silver Project covers 265 mining claims across 13,116 hectares (about 32,410 acres) in Quebec, where the project site was mined for 90 years, and company officers say there is still more potential gold and…

ThursdayMay 22, 2025 10:30 am

Nutriband Inc. (NASDAQ: NTRB) Charts Path to Commercialization

AVERSA Fentanyl has potential to become the world’s first opioid pain patch with abuse deterrent properties, CEO states in report Nutriband and Kindeva Drug Delivery have formalized a strong product-development partnership and long-term commitment Other key steps outlined as company works to develop, scale-up manufacturing process to bring Aversa technology closer toward commercialization In a recent report to shareholders, Nutriband (NASDAQ: NTRB) CEO Gareth Sheridan shared significant company achievements and milestones as well as his expectations for 2025 (https://nnw.fm/cpruz). At the center of the company’s positive outlook for future is noteworthy progress made toward the commercialization of its proprietary Aversa…

ThursdayMay 22, 2025 9:45 am

FAVO Capital Inc. (FAVO): Filling the Financing Gap for Underserved SMBs

FAVO Capital is developing a digital lending platform tailored to small and medium-sized businesses, targeting gaps left by traditional banks Proprietary fintech tools and flexible financing solutions aim to provide capital access for businesses that are often denied by legacy lenders Rising demand for alternative credit sources presents a major opportunity for agile, tech-driven lenders like FAVO With over 5.5 million new business applications filed in the U.S. last year alone, small- to medium-sized businesses (“SMBs”) are thriving, but many are finding themselves underserved by traditional financial institutions. According to recent industry insights, 6 in 10 SMBs are denied access…

ThursdayMay 22, 2025 9:00 am

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Is ‘One to Watch’

The Santa Fe Mine hosts 1.95 million ounces of pit-constrained gold equivalent resources across Indicated and Inferred categories. A 2025 Preliminary Economic Assessment for Santa Fe outlines an after-tax NPV5% of $200 million and a 34.2% IRR based on spot pricing. All four projects are 100%-owned or under low-cost acquisition agreements, with development centered in Nevada, the world’s top mining jurisdiction. Near-term catalysts include Santa Fe permitting milestones, West Santa Fe’s maiden drill program, and an updated economic study. The company is led by a proven team with multiple M&A exits and extensive experience in advancing heap-leach gold operations. Lahontan…

WednesdayMay 21, 2025 10:30 am

ONAR Holding Corp. (ONAR): Building a Martech Powerhouse Through AI and Strategic Acquisitions

ONAR's acquisition-led growth operation is accelerating, with a major marketing tech acquisition set to double revenues at subsidiary Storia AI, data, and automation are at the core of ONAR’s efforts to help middle-market clients achieve measurable marketing performance Fiscal 2024 marked major operational progress, with asset growth, cost reduction, and increasing investor confidence through successful capital raises Marketing in the Age of AI and Data Marketing is undergoing a once-in-a-generation transformation, powered by artificial intelligence, real-time data, and next-generation automation. Today’s marketing systems aren’t static; they’re dynamic, adaptive, and personalized in real time. For growth-stage and middle-market businesses, this shift…

Financial news and publishing for public and private companies

Contact us: 512.354.7000